| Name | N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]arbonyl]-N-2-pyridin |
|---|---|
| Synonyms |
Dabigatran ethyl ester tosylate
Dabigatran Impurity 16 p-Toluenesulfonate Ethyl 3-(((2R,3S,4R)-1-(2-(((4-cbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazol N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfona Dabigatran etexilate/N-2 Ethyl 3-{[(2R,3S,4R)-1-(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)-2,3,4,5-tetrahydroxypentyl](2-pyridinyl)amino}propanoate 4-methylbenzenesulfonate (1:1) (non-preferred name) N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridin Alanine,N- 2- 4-(aMinoiMinoMethyl)phenyl amino Methyl -1-Methyl-1H-benziMidazol-5-yl carbonyl -N-2-pyridinyl-,ethyl ester,4-Methylbenzenesulfonate(1 1) N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfonate Dabigatran impurity 26/Dabigatran ethyl ester tosylate/1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazole-5-cboxylic acid N-(2-pyridyl)-N-(2-ethoxycbonylethyl)amide tosylate β-Alanine, N-[[2-[[[4-(aMinoiMinoMethyl)phenyl]amino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, 4-Methylbenzenesulfonat D-Arabinitol, 1-[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]-1-deoxy-1-[(3-ethoxy-3-oxopropyl)-2-pyridinylamino]-, (1ξ)-, 4-methylbenzenesulfonate (1:1) InterMediates of Dabigatran Dabigatran etexilate-18 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazol-5-yl-carboxylicacid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide para-toluene sulfonate Dabigatran etexilate impurity176 Ethyl 3-(2-(((4-cbaMiMidoylphenyl)amino)Methyl)-1-Methyl-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-cboxaMido)propanoate 4-Methylbenzenesulfonate Dabigatran Impurity 59 DB-7 N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1 Dabigatran ester impurity 18 N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]bonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-methylbenzenesulfonate //BP N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]amino]Methyl]-1- Methyl-1H-benziMidazol-5-yl] carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester 4-Methylbenzenesulfonate 1-methyl-2-[N-[4-amidinophenyl]aminomethyl]benzimidazole-5-carboxylic acid N-(2-pyridyl)-N-(2-ethoxycarbonylethyl)amide tosylate N-[[2-[[[4-(AMinoiMinoMethyl)phenyl]amino]Methyl]-1- Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester tosylate |
| Molecular Formula | C38H47N7O9S |
|---|---|
| Molecular Weight | 777.886 |
| Exact Mass | 777.315613 |
| PSA | 265.82000 |
| LogP | 4.63590 |
|
~92%
872728-85-3 |
| Literature: BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BOEHRINGER INGELHEIM PHARMA GMBH and CO. KG Patent: WO2007/71742 A1, 2007 ; Location in patent: Page/Page column 25 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |